In this issue of Cell Chemical Biology,De Cesare et al. (2018) report the development of a high-throughput assay that measures E2/E3 enzyme activity by MALDI-TOF mass spectrometry and apply this to screen for small molecule E3 inhibitors. This assay potentially accelerates the drug discovery for the ubiquitin ligation pathway.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chembiol.2018.09.002 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!